文献速递角膜与眼表疾病

慢性疼痛疾病与干眼症发病风险的相关性研究

Risk of Incident Dry Eye Disease Among Patients With Chronic Pain Conditions.
PubMed 文献 · Am J Ophthalmol · 2026-07-17

慢性疼痛疾病患者1年干眼症发生率为3.34%对0.72%(RR 4.64),3年累积发生率为7.16%对1.50%(RR 4.78),需处方干眼症3年为0.79%对0.30%(RR 2.60)。结论认为慢性疼痛疾病与干眼症发病及需处方干眼症风险显著相关。

要点

  • 慢性疼痛疾病患者1年干眼症发生风险约为对照的4.64倍。
  • 3年累积干眼症发生率7.16%对1.50%,风险比4.78。
  • 需处方干眼症3年发生率0.79%对0.30%,风险比2.60。

核心结论

  • 慢性疼痛疾病与干眼症发病风险及需处方干眼症风险显著升高相关。
  • 多变量Cox回归显示慢性疼痛疾病独立关联干眼症发病风险升高(HR 4.85)。
  • 验证队列结果与主队列一致。

研究设计与样本

  • 回顾性队列研究,使用TriNetX Analytics Network 2005-2025年成人数据。
  • 暴露组为指数就诊前至少一个慢性疼痛疾病诊断,对照组无慢性疼痛疾病诊断。

主要发现

  • 1年干眼症发生率慢性疼痛疾病组3.34%,对照组0.72%(RR 4.64;95% CI 4.49-4.81;P < .0001)。
  • 3年累积干眼症发生率慢性疼痛疾病组7.16%,对照组1.50%(RR 4.78;95% CI 4.66-4.89;P < .0001)。
  • 3年需处方干眼症发生率慢性疼痛疾病组0.79%,对照组0.30%(RR 2.60;95% CI 2.45-2.75)。
  • 多变量Cox回归中慢性疼痛疾病与干眼症发病风险升高独立相关(HR 4.85;95% CI 4.76-4.94;P < .0001)。

关键数值与推荐

  • 干眼症定义为新诊断干眼综合征或非Sjögren角结膜炎。
  • 需处方干眼症定义为开始使用局部环孢素或lifitegrast。

临床怎么用

  • 在干眼症评估与管理中可考虑将慢性疼痛疾病视为危险因素。
  • 部分干眼症患者可能反映更广泛的疼痛处理异常。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether chronic pain conditions (CPCs) are associated with increased risk of incident dry eye disease (DED) and prescription-requiring DED in a large electronic health record network. DESIGN: Retrospective cohort study. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: Adults aged 18 years or older in the TriNetX Analytics Network (2005-2025) with a qualifying ophthalmology examination and no prior DED diagnosis. The exposure cohort included patients with at least one CPC diagnosis before the index visit; controls had no CPC diagnoses before or after the index visit. After 1:1 propensity score-matching, 538 364 patients were included per cohort. A validation cohort restricted to patients with age-related cataract included 506 763 matched patients per group. METHODS: Patients were identified using ICD-10-CM, SNOMED, and CPT codes. Propensity score matching balanced demographics and comorbidities. Two outcomes were assessed at 1, 2, and 3 years after the index visit: incident DED, defined by a new diagnosis of dry eye syndrome or keratoconjunctivitis sicca not specified as Sjögren's, and prescription-requiring DED, defined by initiation of topical cyclosporine or lifitegrast. Risk ratios with 95% confidence intervals were calculated. Time-to-event analyses used Kaplan-Meier curves and multivariable Cox proportional hazards models. MAIN OUTCOME MEASURES: Incident DED and prescription-requiring DED. RESULTS: Patients with at least one CPC diagnosis had significantly higher risk of incident DED compared with controls at all follow-up intervals. At 1 year, incident DED occurred in 3.34% of the CPC cohort versus 0.72% (RR 4.64; 95% CI, 4.49-4.81; P < .0001). At 3 years, cumulative incidence increased to 7.16% versus 1.50% (RR 4.78; 95% CI, 4.66-4.89; P < .0001). Prescription-requiring DED was also more common in the CPC cohort at 3 years (0.79% vs 0.30%; RR 2.60; 95% CI, 2.45-2.75). In multivariable Cox regression, CPCs were independently associated with increased hazard of incident DED (hazard ratio 4.85; 95% CI, 4.76-4.94; P < .0001). Findings were consistent in the validation cohort. CONCLUSIONS: CPCs are strongly associated with an increased risk of incident and prescription-requiring DED. These findings support consideration of CPCs as risk factors in the evaluation and management of DED and suggest that a subset of patients with DED may reflect broader pain-processing abnormalities.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Fish S, Shmushkevich SB, Zhang C, et al. Risk of Incident Dry Eye Disease Among Patients With Chronic Pain Conditions. Am J Ophthalmol. 2026. PMID: 42468897. doi:10.1016/j.ajo.2026.07.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。